Bioactive Peptide Market refers to Bioactive peptides that are either ingested in foods or produced through biotechnological processes and have valuable therapeutic, nutraceutical, or cosmetic properties.

The Bioburden testing market entails the assessment of microbial presence on products like drugs, equipment and cosmetics among others. This detection establishes the count of the live bacterial count within a given sample to enable a guarantee of the sterility of products. Basically, bioburden testing is a necessity in many industries where it ensures that companies meet set quality standards as well as safeguard the public from dangerous pathogens.

The biodefense market can be defined as the industry specialising in the generation of technologies, products and services that would help protect humanity against biological threats. Some of these threats may be natural epidemics, bioterrorism and biological warfare among people. The market comprises vaccines and diagnostics, therapeutics, and detection systems for use in the surveillance, prevention, and response to such threats. Biodefense strategies are implemented by government, international organizations and private entities in order to protect the population and states ‘security’.